Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Isoflavones, particularly those found in soy, have been studied for their potential benefits to bone health, especially in postmenopausal women. Isoflavones are phytoestrogens—plant-derived compounds with estrogen-like activity—and since estrogen plays a crucial role in maintaining bone density, researchers have investigated whether isoflavones could help mitigate bone loss after menopause.

Several clinical trials and meta-analyses suggest that isoflavone supplementation may have a modest, positive effect on bone mineral density (BMD), particularly in the lumbar spine. For example, a 2015 meta-analysis published in Osteoporosis International indicated that soy isoflavone supplementation resulted in a statistically significant, though small, increase in BMD among postmenopausal women compared to placebo. The effect appears more pronounced in women within five years of menopause and with higher isoflavone intake. However, not all studies have found significant benefits, and the improvements observed are generally less than those achieved with standard pharmacological treatments for osteoporosis.

Overall, while the evidence does not strongly support isoflavones as a primary intervention for bone health, there is scientific rationale and modest clinical evidence for their use in supporting skeletal health—particularly as an adjunct for postmenopausal women at risk of bone loss.

More about Isoflavones (unspecified)
More about Skeletal System (Bones)

Other ingredients that support Skeletal System (Bones)

Other body systems supported by Isoflavones (unspecified)

Products containing Isoflavones (unspecified)